HPV vaccination: Inaccurate assumptions about oropharyngeal cancer

BMJ (Online)

Volumn 339, Issue 7729, 2009, Pages 1045-

  Sturgis, Erich M ^a   Dahlstrom, Kristina R ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER REGISTRY; COST EFFECTIVENESS ANALYSIS; HEALTH PROGRAM; HUMAN; LETTER; OROPHARYNX CANCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

EID: 70449457218     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4525     Document Type: Letter

References (5)

1. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009;339:b3884. (8 October.)[Abstract/Free Full Text]
2. Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 2008;113(10 suppl):2841-2854[Web of Science][Medline]
3. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-1956[Abstract/Free Full Text] (Pubitemid 46740304)
4. Ernster JA, Sciotto CG, O'Brien MM, Finch JL, Robinson LJ, Willson T, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007;117:2115-2128 [CrossRef][Web of Science][Medline] (Pubitemid 351339584)
5. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-475 [Abstract/Free Full Text] (Pubitemid 40270113)